Top Markets
#1 Akedo Akedo +195.32%
#2 ONFA ONFA +54.15%
#3 Talus Network Talus Network +26.48%
#4 0G 0G +21.23%
#5 Osaka Protocol Osaka Protocol +20.92%
#6 Metaplex Metaplex +20.26%
#7 Wrapped Krown Wrapped Krown +19.97%
#8 EVAA Protocol EVAA Protocol +18.16%
#9 eCash eCash +15.89%
#10 Unibase Unibase +15.04%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
Classifica tra le azioni #146
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Prezzo delle azioni
$24.25
Capitalizzazione di mercato
$138.21B
Variazione (1 giorno)
-0.94%
Variazione (1 anno)
194.85%
Paese
US
Scambia Pfizer Inc. (PFE)

Categoria

Healthcare
Rapporto P/B per Pfizer Inc. (PFE)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pfizer Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Pfizer Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 33.0453 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6457 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 15.7899 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 6.509 -
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 7.4763 -
CH